New Study Overturns Assumptions About AFib Treatment in OSA Patients
For decades, sleep apnea has been seen as an obstacle to ablation’s success.
Read MoreFor decades, sleep apnea has been seen as an obstacle to ablation’s success.
Read MoreA respiratory product company is expanding into the sleep therapy market with a portfolio of full face, nasal cushion, and nasal pillow masks for obstructive sleep apnea.
Read MoreA new analysis of phase 3 trial data published in Maturitas supports the efficacy and safety of the dual orexin receptor antagonist for insomnia in this patient population.
Read MoreThe designation for the investigational oral orexin 2 receptor agonist aims to expedite development based on positive phase 2 clinical trial data.
Read MoreSleep Review’s guide compares options on parameters including form factor, wavelengths, sampling rates, optical architecture, and more.
Read More